The document provides information on various aspects of clinical trials including:
- The different phases of clinical trials from Phase 0 to Phase V
- Key elements of a clinical trial protocol such as objectives, design, and methodology
- Regulatory requirements for conducting clinical trials including compliance with ICH GCP guidelines
- Common recruitment strategies and important documents required for clinical trial authorization applications such as the clinical trial protocol, investigator brochure, and informed consent forms.
CFTCC
2015 Learning about the IND/IDE Process and Reimbursements for New Drugs and Devices
Erin O'Reilly, PhD, RAC
Assoc. Director, Regulatory Affairs
Translational Medicine Institute
Introduces the basics of filing an Investigational New Drug (IND) Application with the FDA
CFTCC
2015 Learning about the IND/IDE Process and Reimbursements for New Drugs and Devices
Erin O'Reilly, PhD, RAC
Assoc. Director, Regulatory Affairs
Translational Medicine Institute
Introduces the basics of filing an Investigational New Drug (IND) Application with the FDA
This presentation enlists all the studies which are required before submission of IND. It include IND introduction , time period of study ,flowchart showing preclinical studies...
Presentation working on clinical trialsSarah Henter
Working on Clinical Trials – Getting started
Very few clinical trials are conducted only in one country; many are available in a variety of different sites in different places, so the translation and linguistic adaptation for different target cultures and languages becomes more important – but it’s not easy to find professionals who specialize in this specific field. With my presentation I hope to provide an overview of what makes the linguistic work on clinical trials so special, what kind of texts and target audiences there are and what knowledge linguists need to acquire in order to efficiently work in this area. This is especially interesting for translators who already specialize in the medical field, but also for linguists interested in legal, business, marketing and related field who would like to add an interesting niche with high demand to their specialization.
The presentation aims to be an introduction to the characteristics and requirements of the linguistic work on texts related to clinical trials. It not only wants to give a brief overview of how clinical trials work and who the stakeholders are, but also underline the skills and knowledge set linguists who would like to further specialize in this field should acquire. It also provides them with the necessary resources to get them started. The main topics are as follows:
• Introduction to clinical trials (what are they; how do they work; who is implied)
• Types of documents used in clinical trials (medical [specialist facing/ patient facing]; legal; marketing, etc.)
• Types of audiences (doctors/investigators/healthcare providers; patients/ other laymen such as healthy subjects/ partners/ legal representatives/ parents, etc.; ECs; CROs…)
• What skills do linguists need to work in this field?
• How to acquire that knowledge?
- Where to find glossaries/ templates/ further information
- MOOCs to take to get you started
- Books you should have read
- Other handy resources
This presentation enlists all the studies which are required before submission of IND. It include IND introduction , time period of study ,flowchart showing preclinical studies...
Presentation working on clinical trialsSarah Henter
Working on Clinical Trials – Getting started
Very few clinical trials are conducted only in one country; many are available in a variety of different sites in different places, so the translation and linguistic adaptation for different target cultures and languages becomes more important – but it’s not easy to find professionals who specialize in this specific field. With my presentation I hope to provide an overview of what makes the linguistic work on clinical trials so special, what kind of texts and target audiences there are and what knowledge linguists need to acquire in order to efficiently work in this area. This is especially interesting for translators who already specialize in the medical field, but also for linguists interested in legal, business, marketing and related field who would like to add an interesting niche with high demand to their specialization.
The presentation aims to be an introduction to the characteristics and requirements of the linguistic work on texts related to clinical trials. It not only wants to give a brief overview of how clinical trials work and who the stakeholders are, but also underline the skills and knowledge set linguists who would like to further specialize in this field should acquire. It also provides them with the necessary resources to get them started. The main topics are as follows:
• Introduction to clinical trials (what are they; how do they work; who is implied)
• Types of documents used in clinical trials (medical [specialist facing/ patient facing]; legal; marketing, etc.)
• Types of audiences (doctors/investigators/healthcare providers; patients/ other laymen such as healthy subjects/ partners/ legal representatives/ parents, etc.; ECs; CROs…)
• What skills do linguists need to work in this field?
• How to acquire that knowledge?
- Where to find glossaries/ templates/ further information
- MOOCs to take to get you started
- Books you should have read
- Other handy resources
Guideline on patient safety and well being in clinical trialsTrialJoin
Patient safety is and should be the number one priority in clinical research. Human participants in a clinical trial are necessary in order to improve and develop new therapies for certain conditions and advance the understanding of how a condition can be treated. Such medical advancements wouldn’t be possible without human subjects as participants. However, even though we all know the importance of clinical trials in the advancement of medicine, most people still have some misconceptions regarding this topic.
The feeling of being treated as a ‘’guinea pig’’ and fear of potential risks and side effects are still common among patients who suffer from a certain condition. Such misinformation and misconceptions regarding clinical trials can unnecessarily prevent patients from finding a potential cure or relief, and can also decrease the number of enrolled patients in studies.
In order to clarify these misunderstandings, we’ve decided to tell you everything there is to know about patient safety in clinical trials. We hope that with this information we can help you to better understand patient safety in clinical trials so that you gain more insight and start considering clinical trials as valid options that can help you improve any condition.
SDTM Training for personnel with Junior and Intermediate level Clinical Trial Experience. Covers summary of most domains. Salient features include order of domain creation, importance of making programming Data/Metadata Driven, Nature of Clinical Raw Data, Summary of the Clinical Trial process with regards to the data flow to arrive at the Study data to be submitted to regulatory authorities like FDA, Importance of deriving ADAM from SDTM and not directly from raw data, Information has been put together from variety of sources including my own programming work.
IND (Investigational New Drug) industrial perspectiveAYESHA NAZEER
Describing the Industry's/sponsor's/drug manufacturers' perspective of the Investigational New Drug Application (IND) program based on the survey conducted by the Office Of Inspector General (OIG).
Regulatory requirements for drug approval - industrial pharmacy IIJafarali Masi
Regulatory requirements for drug approval - industrial pharmacy IIDrug Development Teams, Non-Clinical Drug Development, Pharmacology, Drug Metabolism and Toxicology, General considerations of Investigational New Drug (IND) Application, Investigator’s Brochure (IB) and New Drug Application (NDA), Clinical research / BE studies, Clinical Research Protocols, Biostatistics in Pharmaceutical Product Development, Data Presentation for FDA Submissions, Management of Clinical Studies.
Similar to Worldwide comprehensive study of guideline on clinical trial (20)
Tata Group Dials Taiwan for Its Chipmaking Ambition in Gujarat’s DholeraAvirahi City Dholera
The Tata Group, a titan of Indian industry, is making waves with its advanced talks with Taiwanese chipmakers Powerchip Semiconductor Manufacturing Corporation (PSMC) and UMC Group. The goal? Establishing a cutting-edge semiconductor fabrication unit (fab) in Dholera, Gujarat. This isn’t just any project; it’s a potential game changer for India’s chipmaking aspirations and a boon for investors seeking promising residential projects in dholera sir.
Visit : https://www.avirahi.com/blog/tata-group-dials-taiwan-for-its-chipmaking-ambition-in-gujarats-dholera/
What are the main advantages of using HR recruiter services.pdfHumanResourceDimensi1
HR recruiter services offer top talents to companies according to their specific needs. They handle all recruitment tasks from job posting to onboarding and help companies concentrate on their business growth. With their expertise and years of experience, they streamline the hiring process and save time and resources for the company.
Putting the SPARK into Virtual Training.pptxCynthia Clay
This 60-minute webinar, sponsored by Adobe, was delivered for the Training Mag Network. It explored the five elements of SPARK: Storytelling, Purpose, Action, Relationships, and Kudos. Knowing how to tell a well-structured story is key to building long-term memory. Stating a clear purpose that doesn't take away from the discovery learning process is critical. Ensuring that people move from theory to practical application is imperative. Creating strong social learning is the key to commitment and engagement. Validating and affirming participants' comments is the way to create a positive learning environment.
Memorandum Of Association Constitution of Company.pptseri bangash
www.seribangash.com
A Memorandum of Association (MOA) is a legal document that outlines the fundamental principles and objectives upon which a company operates. It serves as the company's charter or constitution and defines the scope of its activities. Here's a detailed note on the MOA:
Contents of Memorandum of Association:
Name Clause: This clause states the name of the company, which should end with words like "Limited" or "Ltd." for a public limited company and "Private Limited" or "Pvt. Ltd." for a private limited company.
https://seribangash.com/article-of-association-is-legal-doc-of-company/
Registered Office Clause: It specifies the location where the company's registered office is situated. This office is where all official communications and notices are sent.
Objective Clause: This clause delineates the main objectives for which the company is formed. It's important to define these objectives clearly, as the company cannot undertake activities beyond those mentioned in this clause.
www.seribangash.com
Liability Clause: It outlines the extent of liability of the company's members. In the case of companies limited by shares, the liability of members is limited to the amount unpaid on their shares. For companies limited by guarantee, members' liability is limited to the amount they undertake to contribute if the company is wound up.
https://seribangash.com/promotors-is-person-conceived-formation-company/
Capital Clause: This clause specifies the authorized capital of the company, i.e., the maximum amount of share capital the company is authorized to issue. It also mentions the division of this capital into shares and their respective nominal value.
Association Clause: It simply states that the subscribers wish to form a company and agree to become members of it, in accordance with the terms of the MOA.
Importance of Memorandum of Association:
Legal Requirement: The MOA is a legal requirement for the formation of a company. It must be filed with the Registrar of Companies during the incorporation process.
Constitutional Document: It serves as the company's constitutional document, defining its scope, powers, and limitations.
Protection of Members: It protects the interests of the company's members by clearly defining the objectives and limiting their liability.
External Communication: It provides clarity to external parties, such as investors, creditors, and regulatory authorities, regarding the company's objectives and powers.
https://seribangash.com/difference-public-and-private-company-law/
Binding Authority: The company and its members are bound by the provisions of the MOA. Any action taken beyond its scope may be considered ultra vires (beyond the powers) of the company and therefore void.
Amendment of MOA:
While the MOA lays down the company's fundamental principles, it is not entirely immutable. It can be amended, but only under specific circumstances and in compliance with legal procedures. Amendments typically require shareholder
Personal Brand Statement:
As an Army veteran dedicated to lifelong learning, I bring a disciplined, strategic mindset to my pursuits. I am constantly expanding my knowledge to innovate and lead effectively. My journey is driven by a commitment to excellence, and to make a meaningful impact in the world.
Buy Verified PayPal Account | Buy Google 5 Star Reviewsusawebmarket
Buy Verified PayPal Account
Looking to buy verified PayPal accounts? Discover 7 expert tips for safely purchasing a verified PayPal account in 2024. Ensure security and reliability for your transactions.
PayPal Services Features-
🟢 Email Access
🟢 Bank Added
🟢 Card Verified
🟢 Full SSN Provided
🟢 Phone Number Access
🟢 Driving License Copy
🟢 Fasted Delivery
Client Satisfaction is Our First priority. Our services is very appropriate to buy. We assume that the first-rate way to purchase our offerings is to order on the website. If you have any worry in our cooperation usually You can order us on Skype or Telegram.
24/7 Hours Reply/Please Contact
usawebmarketEmail: support@usawebmarket.com
Skype: usawebmarket
Telegram: @usawebmarket
WhatsApp: +1(218) 203-5951
USA WEB MARKET is the Best Verified PayPal, Payoneer, Cash App, Skrill, Neteller, Stripe Account and SEO, SMM Service provider.100%Satisfection granted.100% replacement Granted.
Business Valuation Principles for EntrepreneursBen Wann
This insightful presentation is designed to equip entrepreneurs with the essential knowledge and tools needed to accurately value their businesses. Understanding business valuation is crucial for making informed decisions, whether you're seeking investment, planning to sell, or simply want to gauge your company's worth.
Digital Transformation and IT Strategy Toolkit and TemplatesAurelien Domont, MBA
This Digital Transformation and IT Strategy Toolkit was created by ex-McKinsey, Deloitte and BCG Management Consultants, after more than 5,000 hours of work. It is considered the world's best & most comprehensive Digital Transformation and IT Strategy Toolkit. It includes all the Frameworks, Best Practices & Templates required to successfully undertake the Digital Transformation of your organization and define a robust IT Strategy.
Editable Toolkit to help you reuse our content: 700 Powerpoint slides | 35 Excel sheets | 84 minutes of Video training
This PowerPoint presentation is only a small preview of our Toolkits. For more details, visit www.domontconsulting.com
Discover the innovative and creative projects that highlight my journey throu...dylandmeas
Discover the innovative and creative projects that highlight my journey through Full Sail University. Below, you’ll find a collection of my work showcasing my skills and expertise in digital marketing, event planning, and media production.
Premium MEAN Stack Development Solutions for Modern BusinessesSynapseIndia
Stay ahead of the curve with our premium MEAN Stack Development Solutions. Our expert developers utilize MongoDB, Express.js, AngularJS, and Node.js to create modern and responsive web applications. Trust us for cutting-edge solutions that drive your business growth and success.
Know more: https://www.synapseindia.com/technology/mean-stack-development-company.html
Attending a job Interview for B1 and B2 Englsih learnersErika906060
It is a sample of an interview for a business english class for pre-intermediate and intermediate english students with emphasis on the speking ability.
[Note: This is a partial preview. To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
Sustainability has become an increasingly critical topic as the world recognizes the need to protect our planet and its resources for future generations. Sustainability means meeting our current needs without compromising the ability of future generations to meet theirs. It involves long-term planning and consideration of the consequences of our actions. The goal is to create strategies that ensure the long-term viability of People, Planet, and Profit.
Leading companies such as Nike, Toyota, and Siemens are prioritizing sustainable innovation in their business models, setting an example for others to follow. In this Sustainability training presentation, you will learn key concepts, principles, and practices of sustainability applicable across industries. This training aims to create awareness and educate employees, senior executives, consultants, and other key stakeholders, including investors, policymakers, and supply chain partners, on the importance and implementation of sustainability.
LEARNING OBJECTIVES
1. Develop a comprehensive understanding of the fundamental principles and concepts that form the foundation of sustainability within corporate environments.
2. Explore the sustainability implementation model, focusing on effective measures and reporting strategies to track and communicate sustainability efforts.
3. Identify and define best practices and critical success factors essential for achieving sustainability goals within organizations.
CONTENTS
1. Introduction and Key Concepts of Sustainability
2. Principles and Practices of Sustainability
3. Measures and Reporting in Sustainability
4. Sustainability Implementation & Best Practices
To download the complete presentation, visit: https://www.oeconsulting.com.sg/training-presentations
Affordable Stationery Printing Services in Jaipur | Navpack n PrintNavpack & Print
Looking for professional printing services in Jaipur? Navpack n Print offers high-quality and affordable stationery printing for all your business needs. Stand out with custom stationery designs and fast turnaround times. Contact us today for a quote!
RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...BBPMedia1
Marvin neemt je in deze presentatie mee in de voordelen van non-endemic advertising op retail media netwerken. Hij brengt ook de uitdagingen in beeld die de markt op dit moment heeft op het gebied van retail media voor niet-leveranciers.
Retail media wordt gezien als het nieuwe advertising-medium en ook mediabureaus richten massaal retail media-afdelingen op. Merken die niet in de betreffende winkel liggen staan ook nog niet in de rij om op de retail media netwerken te adverteren. Marvin belicht de uitdagingen die er zijn om echt aansluiting te vinden op die markt van non-endemic advertising.
VAT Registration Outlined In UAE: Benefits and Requirementsuae taxgpt
Vat Registration is a legal obligation for businesses meeting the threshold requirement, helping companies avoid fines and ramifications. Contact now!
https://viralsocialtrends.com/vat-registration-outlined-in-uae/
2. Gain a comprehensive overview of the
regulatory requirements for carrying out
clinical trials
Ensure compliance in regulatory requirements
for investigational medicinal products,
pharmacovigilance, and Clinical Trial Data
Management including EDC and e-source
Explore recent developments in clinical trial
regulations including FDA requirements
Achieve successful regulatory inspections.
3. Clinical research is the key to the discovery
of latest diagnostic methods and to
develop modern drugs for treatment of
diseases. Good Clinical Practices (GCP) is
an ethical and scientific quality standard
for designing, conducting and recording
trials that involve the participation of
human subjects.
4. A clinical trial protocol is a document that
describes the objective(s), design,
methodology, statistical considerations,
and organization of a clinical trial
A clinical trial protocol is a document used
to gain confirmation of the trial design by a
panel of experts and adherence by all
study investigators, even if conducted in
various countries.
5. It involves in vitro(test tube or cell culture)
and in vivo(animal) experiments using wide
ranging doses of the study drug to obtain
preliminary efficacy, toxicity and
pharmacokinetics information.
6. Clinical trials involving new drugs are
commonly classified into four phases.
1-Phase 0:- is a recent designation for
exploratory, first in human trial conducted in
accordance with the USFDA 2006 Guidance on
Exploratory IND Studies.
Phase I:- trials are the first stage of testing in
human subjects. Normally, a small (20-100)
group of healthy volunteers will be selected.
This phase includes trials designed to assess
the safety (pharmacovigilance), tolerability,
pharmacokinetics, and pharmacodynamics of
a drug.
7. Phase II:- Once the initial safety of the study
drug has been confirmed in Phase I trials,
Phase II trials are performed on larger groups
(100-300) and are designed to assess how well
the drug works, as well as to continue Phase I
safety assessments in a larger group of
volunteers and patients.
Phase III:- studies are randomized controlled
multicenter trials on large patient groups (300–
3,000 or more depending upon the
disease/medical condition studied) and are
aimed at being the definitive assessment of
how effective the drug is, in comparison with
current 'gold standard' treatment.
8. Phase IV :-trial is also known as Post
marketing surveillance Trial. Phase IV trials
involve the safety surveillance
(pharmacovigilance) and ongoing technical
support of a drug after it receives
permission to be sold.
Phase V:- is a growing term used in the
literature of translational research to refer
to comparative effectiveness research and
community-based research; it is used to
signify the integration of a new clinical
treatment into widespread public health
practice.
9. Clinical trials designed by a local
investigator and (in the U.S.) federally
funded clinical trials are almost always
administered by the researcher who
designed the study and applied for the
grant.
Phase III and Phase IV clinical trials of new
drugs are usually administered by a
contract research organization (CRO) hired
by the sponsoring company.
10. If a clinical trial concerns a new regulated
drug or medical device (or an existing drug
for a new purpose), the appropriate
regulatory agency for each country where
the sponsor wishes to sell the drug or
device is supposed to review all study data
before allowing the drug/device to proceed
to the next phase, or to be marketed.
11. Depending on the kind of participants
required, sponsors of clinical trials use
various recruitment strategies, including
patient databases, newspaper and radio
advertisements, flyers, posters in places
the patients might go (such as doctor's
offices), and personal recruitment of
patients by investigators.
12.
13. The clinical trial sponsor is required to
submit application (Form 44) for the
purpose of conducting clinical trial in India
and submit documents as per Schedule Y
of the Drugs and Cosmetics Act 1940 .
Good Clinical Practice Guidelines issued by
CDSCO, Directorate General of Health
Services, Govt. of India
14. Hard copies:- It must be well labeled with
document number, name of the firm, date
of submission etc.
Soft Copies:- They must be well labeled
with document number, name of the firm,
date of submission etc. Scanned copies of
only signed document like test reports will
be acceptable as soft copies.
15. Introduction about Company
Administrative Headquarters
Manufacturing Facilities
Regulatory permissions/approvals
Regulatory and intellectual property status
in other countries
Patent information status in India & other
countries
16. Product Description
Product Development
Information on Drug Substance
Production of Drug substance
Characterization of Drug substance
Information on Drug Product.
- Description & composition
Components of Drug product
Equipment and Premises
17. India now participates in over 7% of all
global Phase III and 3.2% of all global
Phase II trials1.
Clinical trial outsourcing market in India is
forecast to grow at a compound annual
growth rate of over 30% during 2010-2012
to around $600 million by 2012.
18. Three copies of the application are required:
An archival copy, a review copy, and a field
copy. An application for a new chemical
entity will generally contain an application
form, an index, a summary, five or six
technical sections, case report tabulations
of patient data, case report forms, drug
samples, and labeling, including, if
applicable, any Medication Guide required
19. Investigational New Drug Application:-
clinical investigation is not permitted to
proceed without the prior written
authorization from FDA. FDA shall provide a
written determination 30 days after FDA
receives the IND or earlier.
Responsibilities of Sponsors and
Investigators
20. clinical investigations regulated by the
Food and Drug Administration. as well as
clinical investigations that support
applications for research or marketing
permits for products regulated by the Food
and Drug Administration
Each IRB shall have at least five members,
21. Responsibilities.
Composition, Functions and Operations.
Procedures.
Records.
22. General Information
Background Information
Trial Objectives and Purpose
Trial Design
Selection and Withdrawal of Subjects
Treatment of Subjects
Assessment of Efficacy
Direct Access to Source Data/Documents
Quality Control and Quality Assurance
Data Handling and Record Keeping
23. Request for authorization, applicable
timelines, authorization
Interface with other authorization
requirements
Cover letter
Clinical trial application form
Protocol
Investigator’s brochure
24. Ethics Committee shall give an opinion
within a maximum of 35 days of the date of
receipt of the proposed amendment in
good and due form. If this opinion is
unfavorable, the sponsor may not
implement the amendment to the protocol.
25. The sponsor has to make an end of trial
declaration when the complete trial has
ended in all Member States/third countries
concerned.
The end of trial notification, albeit usually
submitted only subsequently to the end of
trial notification. The sponsor should
provide this summary report within one
year of the end of the complete trial for
non-paediatric clinical trials.
26. Bleichner G et al (1986) work on Frequency of
infections in cirrhotic patients presenting with
acute gastrointestinal haemorrhage.
Lamont JP et al (2003) work on A randomized
trial of valved vs nonvalved implantable ports
for vascular access.
Bien CG et al (2004) work on An open study of
tacrolimus therapy in Rasmussen encephalitis.
Christian G. Bien et al (2009) work on Efficacy
of Tacrolimus and I.V.-
Mouterde G et al (2010) work on Indications of
glucocorticoids in early arthritis and
rheumatoid arthritis
27. Likosky DS et al (2010) work on The effect
of the preoperative blood transfusion and
blood conservation in cardiac surgery .
Robertson D et al (2010) work on SOGC
clinical practice guidelines.
Flint HE et al (2010) work on How well do
reports of clinical trials in the orthodontic .
Carson G et al (2010) work on Alcohol use
and pregnancy consensus clinical
guidelines.
Tolmie EP et al (2011) work on Clinical
Trials: Minimising source data queries to
streamline endpoint adjudication in a large
multi-national trial.
28. Welch RW et al (2011) work on There is
substantial evidence to link what we eat to the
reduction of the risk of major chronic diseases
and/or the improvement of functions.
Parsons NR et al (2011) work on A systematic
survey of the quality of research reporting in
general orthopaedic journals.
Wong S et al (2011) work on SOGC clinical
practice guidelines: Substance use in
pregnancy.
Nankervis H et al (2011) work on Mapping
randomized controlled trials of treatments for
eczema.
29. International Phase I clinical trials with new
chemical entities developed in a foreign
country (first-in-human trials) are not
allowed in India.
prevent the fake clinical trial in India
because the fake clinical trial is real
problem occur.
It should less time taken of the clinical trial
approval in India.
It should be inspected by drug controller
government of India.
30. Brief Study about clinical trial Guideline.
Comparison for Guideline of various
country.
How possible variation in clinical trial
guideline in India.
Study about spurious clinical trial in India
How possible to stop fake clinical trial in
India .
find out the literature survey.
31. After comprehensive study of the USFDA
and ICH guideline I will find out the some
differences like as;
International Conference on Harmonization
(ICH) Guideline covering the conduct of
clinical research studies in the seven
member nations. Guidelines represent the
agency's current thinking on Good Clinical
Practices, but do not bind the FDA or the
public.
32. IRB:-ICH requires that the clinical
investigator provide the Institutional
Review Board (IRB) with a copy of the
Investigator Brochure (4.4.2). FDA only
requires that the pharmaceutical company
sponsor provide it to the investigator.
Documentation of Protocol Deviations:-ICH
requires that the investigator document
and explain any deviation from the study
protocol (4.5.3). FDA does not address this
issue.
Informed Consent:-The elements differ
between ICH (4.8.10) and FDA (50.25a,
50.25b).
33. Financial Records:-
Signed Protocols:-
Indemnification:-
Case Report Form Changes:-